Literature DB >> 34803080

Genetic association of ARID5B with the risk of colorectal cancer within Jammu and Kashmir, India.

Bhanu Sharma1, Shabab Angurana2, Ruchi Shah3, Sonali Verma4, Amrita Bhat1, G R Bhat1, Divya Bakshi1, Rajeshwer Singh Jamwal1, Mukesh Tanwar5, Supinder Singh6, Audesh Bhat7, Samantha Vaishnavi7, Rakesh Kumar1,4.   

Abstract

Colorectal cancer (CRC), which includes the development of cancer from the colon or rectum, is one of the highly prevalent cancers in the populations of Jammu and Kashmir (J&K) in India. However, case-control genetic association studies on CRC are lacking in this population. Various genome-wide association studies have previously shown that single-nucleotide polymorphisms (SNPs) of the AT-rich interaction domain 5B (ARID5B) gene located on chromosome 10q21.2 contribute substantially to the development of colorectal cancer. The association between ARID5B and CRC risk in north Indian population groups is still unknown. To understand the role of ARID5B SNPs in CRC in the population of J&K, we designed a case-control study to investigate the association of the cancer susceptibility variant rs10740055 of ARID5B with CRC in the population of J&K. The study included 180 cases and 390 healthy controls. Genotyping of the rs10740055 variant was performed by RT-PCR using the TaqMan assay technique. Hardy-Weinberg equilibrium of the variant was assessed using the chi-squared test. The allele- and genotype-specific risks were estimated by odds ratios (ORs) with 95% confidence intervals (CIs). The rs10740055 variant showed a higher risk for colorectal cancer with an OR of 3.35 (1.99-5.65 at 95% CI) and P = 0.000005 corrected for age, gender, ethnicity, BMI, alcohol intake and smoking. Our results indicate that the A allele of rs10740055 imparts risk to the population and also that a larger sample size is needed for further statistical validation. The association of other variants in other ARID family genes should also be tested as their role cannot be ruled out.

Entities:  

Keywords:  Jammu and Kashmir (J&K); colorectal cancer (CRC); single-nucleotide polymorphism (SNP)

Mesh:

Substances:

Year:  2021        PMID: 34803080     DOI: 10.1266/ggs.21-00010

Source DB:  PubMed          Journal:  Genes Genet Syst        ISSN: 1341-7568            Impact factor:   1.517


  1 in total

1.  Impact of Variants in the ATIC and ARID5B Genes on Therapeutic Failure with Imatinib in Patients with Chronic Myeloid Leukemia.

Authors:  Karla Beatriz Cardias Cereja Pantoja; Tereza Cristina de Brito Azevedo; Darlen Cardoso de Carvalho; Natasha Monte; Amanda de Nazaré Cohen Paes; Maria Clara da Costa Barros; Lui Wallacy Morikawa Souza Vinagre; Ana Rosa Sales de Freitas; Rommel Mario Rodríguez Burbano; Paulo Pimentel de Assumpção; Sidney Emanuel Batista Dos Santos; Marianne Rodrigues Fernandes; Ney Pereira Carneiro Dos Santos
Journal:  Genes (Basel)       Date:  2022-02-10       Impact factor: 4.096

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.